Status:
COMPLETED
2940nm Er:YAG Laser Versus Benzoyl Peroxide Gel for the Treatment of Inflammatory Acne
Lead Sponsor:
Chulalongkorn University
Conditions:
Acne Vulgaris
Eligibility:
All Genders
18-45 years
Phase:
NA
Brief Summary
Acne is one of the most common conditions that patients seek for help in dermatological clinic. Nowadays, conventional treatment including topical agents(retinoids, antibiotics ,antiseptics and kerato...
Eligibility Criteria
Inclusion
- Age 18 year-old to 45 year-old
- Mild to moderate severity of acne vulgaris with at least 5 active inflammatory acne lesions on each side of the face and less than 25% difference in lesion count between each side of face
- Fitzpatrick skin phototype I-IV
Exclusion
- History or clinical presentation of hypertrophic scar or keloid
- Photoaggravated skin diseases i.e. systemic lupus erythematosus, polymorphous light eruption, solar urticaria
- Oral isotretinoin taken within the last 6 months prior to enrollment
- Topical retinoid within 4 weeks prior to enrollment
- Systemic acne therapies (oral antibiotics) within 4 week prior to enrollment
Key Trial Info
Start Date :
October 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2012
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT01472900
Start Date
October 1 2010
End Date
April 1 2012
Last Update
June 19 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine, Chulalongkorn University
Bangkok, Thailand, 10330